Literature DB >> 2024283

Cyclosporine A for the prevention of neurological deficit following subarachnoid hemorrhage.

M Ryba, P Grieb, J Bidzinski, M Pastuszko, C Dziewiecki, K Iwanska.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024283

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  6 in total

1.  2-Chloro-2' deoxyadenosine prevents angiopathic changes in cerebral arteries in experimental SAH in rabbits.

Authors:  M Ryba; P Grieb; M Walski; J Sawicki; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

2.  Is vascular angiopathy following intracranial aneurysm rupture immunologically mediated?

Authors:  M Ryba; M Jarzabek-Chorzelska; T Chorzelski; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  A strategy for analyzing multiple parameters with application to aneurysmal SAH patients all of them clipped but treated with and without cyclosporine.

Authors:  M Ryba; M Pastuszko; C Dziewiecki; J Andrychowski; P Bojarski; M Barczewska
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

4.  Impaired in vitro proliferative response of suppressor lymphocytes in patients with subarachnoid haemorrhage from ruptured intracranial aneurysm.

Authors:  M Ryba; P Grieb; M Pastuszko; B Wegier-Filipiuk; E Mrowiec; J Andrychowski; L Konopka
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

5.  Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine.

Authors:  M Ryba; P Grieb; M Pastuszko; J Bidziński; J Andrychowski; C Dziewiecki; P Bojarski; L Królicki
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 6.  Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage.

Authors:  Brandon A Miller; Nefize Turan; Monica Chau; Gustavo Pradilla
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.